FOI 25-1421 – Report On Ticks

Written by Claude Haiku 4.5 from the extracted text on 27 Feb 2026. It can miss or misread redacted and scanned pages. Check the source before relying on it.

The Department of Health commissioned a stakeholder engagement strategy (March 2019) to support development of a clinical pathway and multidisciplinary care model for patients with debilitating symptom complexes attributed to ticks (DSCATT). The strategy outlines consultation approaches involving key stakeholders including medical professionals, government health authorities, and patient groups across multiple states. Engagement methods include a Think Tank forum and face-to-face consultation meetings in Melbourne, Sydney, Canberra, Perth, and Brisbane, plus virtual consultations with state health departments and patient groups. The clinical pathway development aimed to produce evidence-based guidance acceptable to the Australian Health Ministers' Advisory Council and relevant health protection and clinical committees for application across private and public healthcare settings. The document provides procedural frameworks for stakeholder identification and engagement principles but does not contain specific clinical efficacy data, safety assessments, or regulatory outcomes regarding tick-borne illness management.